FINWIRES · TerminalLIVE
FINWIRES

$ARGX

30 stories mentioning ARGXUpdated 29m ago

Every FINWIRES story that references ARGX, newest first.

Asia Markets

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

European equities traded in the US as American depositary receipts were tracking sharply higher late Thursday morning, rising 1.84% to 1,938.04 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and lender ING Group (ING), which advanced 9.8% and 7% respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria (BBVA) and Banco Santander (SAN), which climbed 6.8% and 4.6% respectively.The decliners from continental Europe were led by pharmaceutical company Sanofi (SNY) and software firm SAP (SAP), which lost 6.2% and 2.8% respectively. They were followed by internet ad firm Criteo (CRTO) and biopharmaceutical company argenx (ARGX), which dropped 2.5% and 1.8% respectively.The gainers from the UK were led by lenders Barclays (BCS) and Lloyds Banking Group (LYG), which rose 5.6% and 5.4% respectively. They were followed by insurance firm Prudential (PUK) and biopharmaceutical company Mereo BioPharma Group (MREO), which were up 4.8% and 1.6% respectively.The decliners from the UK and Ireland were led by software firm Endava (DAVA) and communications company WPP (WPP), which fell 6.4% and 5.8% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which were down 4.4% and 2.9% respectively.

$AKTX$ARGX$BBVA$BCS$CRTO$DAVA$ING$LYG$MREO$NOK$PUK$SAN$SAP$SNY$TRIB$WPP
Sectors

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.8%.The iShares Biotechnology ETF (IBB) advanced 0.7%.In corporate news, Forte Biosciences (FBRX) shares soared 39% after it agreed to be acquired by Argenx (ARGX) in a deal worth about $2.2 billion. Argenx shares were down 2.5%.AstraZeneca (AZN) shares were up 0.8% after it posted higher Q2 core earnings and revenue, and raised its interim dividend.Ensign (ENSG) shares climbed nearly 3% after it reported higher Q2 adjusted earnings and revenue, and raised its 2026 outlook.Veru (VERU) said Monday it has completed enrollment in a phase 2 trial evaluating its experimental drug enobosam in combination with semaglutide, in about 200 adults aged 65 and older with obesity. Veru shares gained 3.1%.

$ARGX$AZN$ENSG$FBRX$VERU
Asia Markets

Update: US Equity Indexes Mixed as Tech Heads Lower, Crude Oil Sinks on Pause in Iran Strikes

(Updates with index/price moves, macroeconomic data, and company/geopolitical news from the first paragraph.)US equity indexes traded mixed as investor concerns grew over circular investments in the artificial intelligence industry and as crude oil prices plunged after a pause in Iran strikes entered its third day.The Dow Jones Industrial Average climbed 0.2% to 52,022.2 after midday Monday. The Nasdaq Composite retreated 0.7% to 24,809.9, and the S&P 500 declined 0.4% to 7,385.5.Energy and technology led decliners while communication services and consumer staples topped the gainers.Nvidia (NVDA) has agreed to expand its partnership with South Korean conglomerate SK Group through an artificial intelligence infrastructure initiative valued at more than $500 billion. The deal announced Saturday includes a long-term partnership between Nvidia and SK Hynix (SKHY) that will provide the US technology giant a stable supply of next-generation AI memory. Nvidia's shares dropped 5.1%, the Dow's steepest decliner. The SK Hynix stock plummeted 9.6%.VanEck Semiconductor ETF (SMH), with net assets of $77.2 billion, slumped 3.7%.In geopolitical news, the US paused military attacks against Iran over the weekend, while Tehran also refrained from retaliatory action, according to a Commerzbank note. Meanwhile, Oman and Iran continued discussions on a transit arrangement for the Strait of Hormuz, with diplomats describing the negotiations as "moving in the right direction." Iranian officials likewise characterized the talks as "constructive."Mediators have achieved progress in getting the US and Iran back to negotiations, the Associated Press reported, citing regional officials. The two regional officials said mediators led by Qatar and Pakistan were working to bridge the gap between Washington and Tehran to return to an interim ceasefire deal that had collapsed after the exchanges of fire, the news report said.The front-month US West Texas Intermediate sank 7.4% to $82.72 a barrel, and global benchmark North Sea Brent plunged 8% to $89.06 a barrel.Most US Treasury yields fell, with the 10-year down 3.4 basis points to 4.65% and the two-year lower by 1.9 basis points to 4.31%.In precious metal markets, gold futures rose 0.4% to $4,087.1, and silver futures edged up 0.2% to $59.05.Further in company news, Forte Biosciences (FBRX) shares surged 40% after the company agreed to be acquired by Belgian-Dutch immunology firm argenx (ARGX) in a deal worth about $2.2 billion.Baker Hughes (BKR) shares jumped 6.6% after the company posted Q2 adjusted earnings and revenue that topped analysts' expectations.In economic news, new orders for US durable goods rose by 0.3% in June following a decline of 4.0% in May compared with the expectations for a larger increase of 1.8% in a survey compiled by Bloomberg. Excluding a 0.2% decrease in transportation orders, new orders would have been up 0.6% in June after a 1.8% increase in May. Expectations were for a 0.8% gain.The Dallas Fed's monthly manufacturing index rose to 1.3 in July from zero in June, below expectations for a 2.0 print.

Dow JonesNasdaq CompositeS&P 500$ARGX$BKR$FBRX$NVDA$SKHY$SMH
Sectors

Sector Update: Healthcare Stocks Advance Monday Afternoon

Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index rising 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.9%.The iShares Biotechnology ETF (IBB) advanced 0.5%.In corporate news, Forte Biosciences (FBRX) shares soared 39% after it agreed to be acquired by Argenx (ARGX) in a deal worth about $2.2 billion. Argenx shares were down 2.2%.AstraZeneca (AZN) shares were up marginally after it posted higher Q2 core earnings and revenue, and raised its interim dividend.Ensign (ENSG) shares climbed 4% after it reported higher Q2 adjusted earnings and revenue, and raised its 2026 outlook.

$ARGX$AZN$ENSG$FBRX
Sectors

Sector Update: Healthcare

Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index rising 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.9%.The iShares Biotechnology ETF (IBB) advanced 0.7%.In corporate news, Forte Biosciences (FBRX) shares soared 39% after it agreed to be acquired by Argenx (ARGX) in a deal worth about $2.2 billion. Argenx shares were down 2%.

$ARGX$FBRX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading

European equities traded in the US as American depositary receipts started the week slightly higher late Monday morning, rising 0.15% to 1,910.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP (SAP) and lender Banco Santander (SAN), which rose 6% and 3.5% respectively. They were followed by biotech firm Evaxion (EVAX) and biopharmaceutical company Grifols (GRFS), which increased 3.3% and 3.2% respectively.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which fell 3% and 2.6% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and biopharmaceutical company argenx (ARGX), which were down 1.8% and 0.7% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and telecommunications operator Vodafone Group (VOD), which climbed 9.6% and 5.4% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which advanced 5.2% and 4.4% respectively.The decliners from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which dropped 2% and 1% respectively. They were followed by tobacco company British American Tobacco (BTI) and utilities company National Grid (NGG), which lost 0.6% and 0.1% respectively.

$AKTX$ARGX$AUTL$BP$BTI$BUD$E$EQNR$EVAX$GRFS$NGG$SAN$SAP$SHEL$SLN$VOD
Sectors

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.4% and the iShares Biotechnology ETF (IBB) advancing by 0.5%.AstraZeneca (AZN) stock was up 0.8% after the company posted higher Q2 core earnings and revenue, and raised its interim dividend.Ensign Group (ENSG) shares were up nearly 11% after the company reported higher Q2 adjusted earnings and revenue, and raised its 2026 outlook.Argenx (ARGX) has agreed to buy Forte Biosciences (FBRX) for $77 per share in cash. Shares of Forte Biosciences were up more than 39% pre-bell.

$ARGX$AZN$ENSG$FBRX$IBB$XLV
Stocks Rise Pre-Bell as US, Iran Pause Strikes; Fed Policy Decision, Inflation Report on Deck
US Markets

Stocks Rise Pre-Bell as US, Iran Pause Strikes; Fed Policy Decision, Inflation Report on Deck

The benchmark US stock measures were pointing higher before the opening bell Monday after the US and Iran halted strikes over the weekend, while traders gear up for a busy week that includes a major policy decision by the Federal Reserve, a key inflation report and earnings.The S&P 500 and the Dow Jones Industrial Average rose 0.8% each in premarket activity, while the Nasdaq increased 1.4%. The S&P 500 and the Dow finished Friday's trading session in the green, while the Nasdaq closed lower.After 13 consecutive nights of strikes against Iran, no US attacks against Tehran were officially announced over the weekend. Iran said it will also halt its attacks as long as the US does the same, a senior Iranian official told Reuters on Sunday.West Texas Intermediate crude oil dropped 6.4% to $83.56 a barrel before the open, while Brent fell 8% to $89.06.The US ambassador to the United Nations Mike Waltz reportedly told Fox News on Sunday that President Donald Trump has paused strikes against Iran to give talks "some space."Iranian Foreign Ministry spokesman Esmail Baghaei said technical talks with Oman on the Strait of Hormuz continued over the weekend, CNBC reported.Meanwhile, Iran summoned Ukraine's charge d'affaires in Tehran on Sunday over an attack on an Iranian commercial vessel in the Caspian Sea, calling it a "hostile and criminal act," according to a separate CNBC report.The Fed's monetary policy committee is scheduled to meet on Tuesday, with a decision on interest rates due the following day. The probability the central bank will leave its benchmark lending rate unchanged currently stands at 69%, with the remaining odds in favor of a quarter-percentage-point increase, according to the CME FedWatch tool.Traders also await the personal income and outlays report for June later in the week. The report includes the personal consumption expenditure core price index, the Fed's preferred inflation metric.Treasury yields were down in premarket action, with the two-year rate retreating 2.6 basis points to 4.31% and the 10-year rate off 3.8 basis points to 5.12%.Monday's economic calendar has the durable goods orders report for last month at 8:30 am ET, followed by the Dallas Fed manufacturing survey for July at 10:30 am.Tech giants Microsoft (MSFT), Apple (AAPL), Amazon (AMZN) and Meta Platforms (META) are scheduled to release their latest financial results later this week, along with Visa (V), Mastercard (MA), ExxonMobil (XOM), Coca Cola (KO), Procter & Gamble (PG), Qualcomm (QCOM) and Boeing (BA).Shares of Forte Biosciences (FBRX) jumped 39% pre-bell after it agreed to be acquired by Belgian-Dutch immunology firm argenx (ARGX) in a deal worth roughly $2.2 billion. AstraZeneca's (AZN) US-listed stock gained 1.4% after the company reported its latest quarterly results.Gold inclined 0.7% to $4,098 per troy ounce, while bitcoin advanced 1.1% to $65,350.

Dow JonesNasdaq CompositeS&P 500$AAPL$AMZN$ARGX$AZN$BA$FBRX$KO$MA$META$MSFT$PG$QCOM$V$XOM
Forte Biosciences Agrees to Be Acquired by Argenx in $2.2 Billion Deal
US Markets

Forte Biosciences Agrees to Be Acquired by Argenx in $2.2 Billion Deal

Forte Biosciences (FBRX) shares surged early Monday after the company agreed to be acquired by Belgian-Dutch immunology firm argenx (ARGX) in a deal worth about $2.2 billion.A wholly owned subsidiary of argenx will launch a cash tender offer to purchase all Forte Biosciences shares at $77 apiece, the companies said in a joint statement. The tender offer will be followed by a merger, with shares not tendered converted into the right to receive the same $77 per share in cash.The consideration represents a premium of about 86% to Forte Biosciences' volume-weighted average price as of July 9, according to the firms. Forte Biosciences' stock jumped 39% in the most recent premarket activity, while argenx's Nasdaq-listed shares were down 0.7%.The acquisition is expected to give argenx access to Forte Biosciences' lead program, FB102, for vitiligo and celiac disease, expanding its immunology portfolio. A Phase 1b clinical trial in vitiligo showed the candidate demonstrated statistically "significant treatment benefit," the statement said. The company also reported positive Phase 1b data for FB102 in celiac disease last year, with Phase 2 results expected in the second half of this year.The program also has the potential to address alopecia areata and additional autoimmune diseases, the companies added."The addition of FB102 to our portfolio aligns perfectly with the argenx playbook: compelling biology, strong clinical validation and broad potential to address patient need," argenx Chief Executive Karen Massey said. "Together, we look forward to unlocking the full potential of FB102 and accelerating its impact for patients."The transaction is anticipated to complete in the third quarter."By combining FB102's promising clinical profile with argenx's proven development expertise, global reach and commercial capabilities, we have a unique opportunity to accelerate its development and maximize its impact for patients," Forte Biosciences CEO Paul Wagner said.In May, Forte Biosciences reported a first-quarter net loss of $1.24 a share, compared with a net loss of $1.37 the year before.

$ARGX$FBRX
Wire

Argenx's Vyvgart Beat Impressive With Focus On Upcoming Myositis Data, RBC says

Argenx's (ARGX) Vyvgart posted a strong Q2 beat on organic demand in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, prefilled syringe uptake, and a label expansion, RBC Capital Markets said in a note emailed Friday.The firm highlighted that most payers have dropped serology testing requirements ahead of treatment, potentially removing an adoption barrier, while Japan results included a one-time benefit tied to a wholesaler distribution change.RBC said sequential growth topped prior-year trends, suggesting sales may be inflecting further ahead of a potential ocular myasthenia gravis label expansion.RBC noted the pivotals for both myositis and multifocal motor neuropathy are on track to read out in the second half of the year.RBC maintained its outperform rating and increased the price target to 1,025 from $945.Price: $918.54, Change: $-6.06, Percent Change: -0.66%

$ARGX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, falling 0.9% to 1,901.24 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and medical device maker EDAP TMS (FOCL), which rose 5.3% and 4.4% respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which were up 3.7% and 2.1% respectively.The decliners from continental Europe were led by biopharmaceutical company Grifols (GRFS) and lender Banco Santander (SAN), which dropped 4.2% and 3.6% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and accommodations booking site trivago (TRVG), which lost 3.1% and 2.9% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which advanced 2.8% and 2.3% respectively. They were followed by oil and gas company Shell (SHEL), which increased 1.6%.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and tobacco company British American Tobacco (BTI), which fell 5.4% and 3.3% respectively. They were followed by alcoholic beverage company Diageo (DEO) and educational publisher Pearson (PSO), which were down 2.4% and 0.4% respectively.

$ARGX$BP$BTI$BUD$DEO$E$EQNR$FOCL$GRFS$MREO$PSO$SAN$SHEL$TRIB$TRVG
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were climbing sharply higher late Tuesday morning, rising 1.57% to 1,909.91 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company argenx (ARGX), which rose 5.5% and 2.3% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA)and oil and gas company Eni (E), which were up 2.2% and 0.9% respectively.The decliners from continental Europe were led by software firm SAP (SAP) and consumer goods company Unilever (UL), which fell 1.7% and 1.3% respectively. They were followed by healthcare tech company Royal Philips (PHG) and 3D printer company Materialise (MTLS), which were down 1% and 0.8%. respectivelyThe gainers from the UK were led by mining company BHP Group (BHP) and lender Lloyds Banking Group (LYG), which advanced 2.7% and 2.1%, respectively. They were followed by lender Barclays (BCS) and biotech firm Autolus Therapeutics (AUTL), which gained 2% and 0.9%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and communications company WPP (WPP), which lost 6.3% and 4.3% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and tobacco company British American Tobacco (BTI), which dropped 1.2% and 1% respectively.

$AKTX$ARGX$AUTL$BBVA$BCS$BHP$BTI$E$LYG$MTLS$NOK$PHG$SAP$UL$VOD$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline Friday

European equities traded in the US as American depositary receipts were lower on Friday morning, shedding 0.2% to 1,899.89 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by steel producer ArcelorMittal (MT) and bank BBVA (BBVA), which rose 5.2% and 1.4% respectively.They were followed by technology company Opera (OPRA), which added 0.9%.The decliners from continental Europe were led by clinical-stage biopharmaceutical company Inventiva (IVA) and technology company Nokia (NOK), which fell 5.6% and 4.2% respectively.They were followed by pharmaceutical company Argenx (ARGX), which shed 3.6%.From the UK and Ireland, the gainers were led by telecom giant Vodafone (VOD) and advertising agency WPP (WPP), which rose 13% and 4.9% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biotech company Autolus Therapeutics (AUTL), which lost 7% and 6.8% respectively.

$ARGX$AUTL$BBVA$IVA$MT$NOK$OPRA$SLN$VOD$WPP
Asia Markets

European Equities Traded in US as ADRs Rise in Thursday Trading

European equities traded in the US as American depositary receipts rose late Thursday morning with the S&P Europe Select ADR Index gaining 1.3% to 1,893.21.From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and DBV Technologies (DBVT), which rose 4.2% and 3.5%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and health tech company Royal Philips (PHG), which were up 3.2% and 2.7%, respectively.The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and medical device maker EDAP TMS (FOCL), which dropped 2.7% and 2.6%, respectively. They were followed by biotech firm Evaxion (EVAX) and oil and gas company Eni (E), which were down 2.4% and 1.7%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and lender Lloyds Banking Group (LYG), which advanced 8.8% and 2.8%, respectively. They were followed by lender Barclays (BCS) and insurance company Prudential (PUK), which increased 2.6% and 2.5%, respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which fell 3.5% and 3%, respectively. They were followed by oil and gas company Shell (SHEL), which was off 0.4%.

$ARGX$BCS$CLLS$CRTO$DAVA$DBVT$E$EVAX$FOCL$LYG$PHG$PUK$SHEL$SLN$TRIB
Research

BNP Paribas Initiates argenx at Outperform With $1,219 Price Target

argenx (ARGX) has an average rating of buy and mean price target of $1,064.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ARGX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were sharply higher late Wednesday morning, rising 1.28% to 1,926.15 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which advanced 2.5% and 2.3% respectively. They were followed by biopharmaceutical firm argenx (ARGX) and biotech firm BioNTech (BNTX), which rose 2.1% and 2% respectively.The decliners from continental Europe were led by pharmaceutical company Sanofi (SNY) and telecommunications company Nokia (NOK), which dropped 2% and 1.4% respectively. They were followed by software firm SAP (SAP) and telecommunications company Ericsson (ERIC), which were off 1% and 0.8% respectively.The gainers from the UK were led by Mereo BioPharma Group (MREO) and lender Barclays (BCS), which rose 9% and 3.6% respectively. They were followed by Akari Therapeutics (AKTX) and Bicycle Therapeutics (BCYC), which advanced 3.3% and 2.7% respectively.The decliners from the UK and Ireland were led by British American Tobacco (BTI) and telecommunications operator Vodafone Group (VOD), which fell 8% and 1.3% respectively. They were followed by oil and gas companies BP (BP) and Shell (SHEL), which were down 1.1% and 1% respectively.

$AKTX$ARGX$BBVA$BCS$BCYC$BNTX$BP$BTI$ERIC$MREO$NOK$SAN$SAP$SHEL$SNY$VOD
Asia Markets

European Equities Traded in US as ADRs Rise in Thursday Trading

European equities traded in the US as American depositary receipts rose late Thursday morning with the S&P Europe Select ADR Index climbing 1.7% to 1,874.97.From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications (SQNS), which rose 2.7% and 2.6%, respectively. They were followed by biotech firm BioNTech (BNTX) and telecommunications company Nokia (NOK), which were up 2.5% and 1.6%, respectively.The decliners from continental Europe were led by software firm SAP (SAP) and internet ad firm Criteo (CRTO), which dropped 4.1% and 0.9%, respectively. They were followed by biotech firm Evaxion (EVAX) and consumer goods company Unilever (UL), which were off 0.4% and 0.1%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which climbed 8.8% and 4%, respectively. They were followed by lender HSBC (HSBC) and biotech firm Autolus Therapeutics (AUTL), which advanced 2.8% and 2.7%, respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which fell 4.6% and 1.1%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and NuCana (NCNA), which lost 0.9% and 0.8%, respectively.

$ARGX$AUTL$BDRX$BNTX$CRTO$DAVA$EVAX$HSBC$MREO$NCNA$NOK$SAP$SLN$SQNS$TRIB$UL
Research

William O'Neil Initiates argenx at Buy

argenx SE ADR (ARGX) has an average rating of buy and mean price target of $1,058.49, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ARGX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week

European equities traded in the US as American depositary receipts were tracking lower late Friday morning, falling 0.85% to 1,882.19 on the S&P Europe Select ADR Index, which is up 0.9% for the week so far.From continental Europe, the gainers were led by internet ad firm Criteo (CRTO) and consumer goods company Unilever (UL), which rose 2.1% and 2% respectively. They were followed by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which were up 1.8% and 0.7% respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which dropped 8.3% and 7.2% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which lost 5.4% and 2.9% respectively.The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and alcoholic beverage company Diageo (DEO), which advanced 4.5% and 2.4% respectively. They were followed by tobacco company British American Tobacco (BTI) and educational publisher Pearson (PSO), which increased 2.1% and 1.9% respectively.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and mining company BHP Group (BHP), which lost 6.3% and 5.3% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which dropped 3% and 2.2% respectively.

$AKTX$ARGX$AUTL$BHP$BTI$CLLS$CRTO$DBVT$DEO$ERIC$NOK$PSO$SLN$SQNS$TRIB$UL
Asia Markets

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were declining late Wednesday morning, falling 0.58% to 1,880.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and petroleum refiner Equinor (EQNR), which rose 2.1% and 1.3%, respectively. They were followed by oil and gas company Eni (E) and biopharmaceutical company argenx (ARGX), which were up 1% and 0.5%, respectively.The decliners from continental Europe were led by internet ad firm Criteo (CRTO) and biopharmaceutical company Cellectis (CLLS), which fell 7% and 4.7%, respectively. They were followed by biotech firm Evaxion (EVAX) and software company SAP (SAP), which were down 4.6% and 4.5%, respectively.The gainers from the UK were led by Mereo BioPharma Group (MREO), which advanced 5.6%. It was followed by pharmaceutical company Silence Therapeutics (SLN) and medical device maker Smith & Nephew (SNN), which increased 4.8% and 2%, respectively.The decliners from the UK and Ireland were led by communications company WPP (WPP) and software company Endava (DAVA), which dropped 4.5% and 4.4%, respectively. They were followed by lender Barclays (BCS) and biotech firm Autolus Therapeutics (AUTL), which lost 2.4% and 1.7%, respectively.

$ARGX$AUTL$BCS$CLLS$CRTO$DAVA$E$EQNR$EVAX$MREO$NCNA$NOK$SAP$SLN$SNN$WPP

Showing 1-20 of 30

Track with the FINWIRES app suite

FolioX
FolioX
Track ARGX in your portfolio
WheelAI
WheelAI
Analyze ARGX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on ARGX